Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8922459 | Clinical and Translational Radiation Oncology | 2017 | 6 Pages |
Abstract
RINV in VMAT breast radiotherapy could be a new emerging acute side effect due to a low dose bath to upper abdominal structures such as the GEJCPs. A Dmaxâ¯<â¯10â¯Gy and Dmeanâ¯<â¯3â¯Gy to GEJCPs should be constrained in VMAT planning to minimize RINV risk in breast radiotherapy.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
G. Lazzari, A. Terlizzi, M.G. Leo, G. Silvano,